Stay updated on Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Sign up to get notified when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The ClinicalTrials.gov page now presents the study record for the SB-913 gene-editing trial in MPS II, including its status, study details, outcomes, and eligibility information, instead of a 403 error page.
    Difference
    55%
    Check dated 2026-11-07T12:13:46.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0 while the page continued to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-31T12:57:29.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    An NIH site-wide notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-24T15:38:00.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page remains a 403 Forbidden error page, with its footer revision changing from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T15:17:55.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-10T16:05:12.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    A 403 Forbidden error page now appears for the study record, replacing the previous detailed study information and associated documents.
    Difference
    19%
    Check dated 2026-09-19T20:46:22.000Z thumbnail image

Stay in the know with updates to Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ascending Dose Study of ZFN Therapeutic SB-913 in MPS II Clinical Trial page.